Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

NCT00004870 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: oblimersen sodium
DRUG: irinotecan hydrochloride

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]